Immunonutrition in patients with pancreatic cancer undergoing surgical intervention: A systematic review and meta-analysis of randomized controlled trials

研究成果: 雜誌貢獻回顧型文獻同行評審

1 引文 斯高帕斯(Scopus)

摘要

Immunonutrition is administered to improve the outcome of patients with pancreatic cancer undergoing surgery. However, its effect and mechanism of action remain unclear. Therefore, we conducted this systematic review and meta-analysis to assess its effects on postoperative outcome and the immune system. Randomized controlled trials (RCTs) were identified and data extracted by two reviewers independently from electronic databases from their inception to 31 October 2019. The result was expressed as the risk ratio (RR) for categorical variables and mean difference (MD) for continuous variables with 95% confidence intervals (CIs). Six RCTs published from 1999 and 2016, with a total of 368 patients, were included. The results revealed that immunonutrition significantly decreased the rate of infectious complications (RR = 0.47, 95% CI (0.23, 0.94), p = 0.03) and the length of hospital stay (MD = −1.90, 95% CI (−3.78, −0.02), p = 0.05) by modulating the immune system, especially in preoperative group in subgroup analysis. We therefore recommend that patients with pancreatic cancer undergoing surgery could take the advantage of immunonutrition, especially in the preoperative period.
原文英語
文章編號2798
頁(從 - 到)1-16
頁數16
期刊Nutrients
12
發行號9
DOIs
出版狀態已發佈 - 九月 2020

ASJC Scopus subject areas

  • 食品科學
  • 營養與營養學

指紋

深入研究「Immunonutrition in patients with pancreatic cancer undergoing surgical intervention: A systematic review and meta-analysis of randomized controlled trials」主題。共同形成了獨特的指紋。

引用此